Skip to main content
Clinical Trials/NCT06380257
NCT06380257
Not yet recruiting
Not Applicable

Anorexia Nervosa and Brain in Adolescence

Kuopio University Hospital0 sites50 target enrollmentSeptember 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Anorexia Nervosa
Sponsor
Kuopio University Hospital
Enrollment
50
Primary Endpoint
Neuroimaging
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

Aims of this follow-up study are to investigate effects of anorexia nervosa on brain structure and functions in adolescence.

Detailed Description

Anorexia nervosa is severe mental health problem with increased incidence rates in adolescence. Etiology of anorexia nervosa is still mostly unkonwn. Adolescence is also critical period of brain development. Aims of this follow-up study are to investigate effects of anorexia nervosa on brain structure and functions in both acute and remission state of anorexia nervosa in adolescence. Study group are young anorexia nervosa patients, and control group are healthy same-aged students. Research methods include non-invasive brain imaging methods such as Transcranial Magnetic Stimulation (TMS), and Magnetic Resonance Imaging (MRI). Other research methods are assessment of body composition, laboratory tests, self-rated questionnaires and psychiatric interview.

Registry
clinicaltrials.gov
Start Date
September 2024
End Date
December 2030
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Kuopio University Hospital
Responsible Party
Principal Investigator
Principal Investigator

Virve Kekkonen

Specialist in adolescent psychiatry, clinical lecturer

Kuopio University Hospital

Eligibility Criteria

Inclusion Criteria

  • Study group: 1) age 16-19 years, 2) BMI below 17.5, 3) diagnosis: anorexia nervosa or atypical anorexia nervosa 4) diagnosed within last two years. Inclusion criteria.
  • Control group : 1) age 16-19 years, 2) BMI over 19.0, 3) No lifetime obesity (BMI over 30) nor eating disorder.

Exclusion Criteria

  • glucose metabolism disorder or any chronic medical disorder, or medicine with possible effects on neurotransmitters, 2) previous mental health problem (excluded anorexia nervosa or atypical anorexia nervosa in study group), 3) smoking, nicotine products, alcohol or any other substance abuse or dependence, 4) contraindication for used brain imaging method.

Outcomes

Primary Outcomes

Neuroimaging

Time Frame: Baseline and at 3 years' follow-up

Transcranial magnetic stimulation (TMS) combined with electroencephalogram (EEG)

Secondary Outcomes

  • Neuroimaging(Baseline and at 3 years' follow-up)

Similar Trials